Moderna missed earnings forecasts, posting a net loss of $1.1 billion, or $2.91 per share, 23% below the expectations of analysts polled by Visible Alpha. Revenue was 4% higher than forecasts ...

Even though Nikke is one of the most generous gacha games out there, it can take a lot of rolls to get your favorite waifus. To save up those precious Gold Mileage Tickets and Gems for future ...

US gives conditional nod to Zoetis' bird flu vaccine for poultry Healthcare & Pharmaceuticalscategory· February 14, 2025 Moderna said on Friday that the U.S. FDA paused a late-stage trial of its ...

Shares in Moderna were ticking upwards today after Merck & Co took up an option on a personalised RNA-based cancer vaccine with a payment of $250 million. It is the first time that Merck has ...

MSD and partner Moderna have started a late-stage trial of their personalised cancer vaccine V940 as a combination with MSD’s PD-1 inhibitor Keytruda for patients with non-small cell lung cancer ...

In its fourth-quarter earnings report, Moderna’s revenue was down substantially from 2023. Separately, media reports reveal anticipated cuts to the company’s digital team. Moderna continues to ...

The earth is in danger, my deadly Nikkes, and I need to save it from destruction in Goddess of Victory: Nikke! Alien robots have overrun the earth, and my hybrid group of Nikke needs to shoot down any ...